Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Evaluation of Lymphocyte Immunity in Patients Treated with Venetoclax-Azacitidine for Acute Myeloid Leukemia

Minoru Kanaya, Toma Suzuki, Sayaka Kajikawa, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Masanobu Morioka, Akio Mori, Toshihiro Matsukawa, Masahiro Onozawa, Takanori Teshima, Takeshi Kondo

Blood (2024) 144 (Supplement 1): 6061.

https://doi.org/10.1182/blood-2024-198084

Published: 2024

Journal Articles

Combination of Low White Blood Cell Count and Impaired Renal Function Is a Risk Factor for Higher Concentrations of Venetoclax and Prolonged Neutropenia in AML Patients with Venetoclax Combined Regimen: Real World Experience in the Japanese Cohort

Minoru Kanaya, Yuji Mukai, Mirei Kobayashi, Sayaka Kajikawa, Toma Suzuki, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Masanobu Morioka, Akio Mori, Toshihiro Matsukawa, Masahiro Onozawa, Goichi Yoshimoto, Mitsuru Moriyama, Sunggi Chi, Takanori Teshima, Yosuke Minami, Masato Honmma, Takeshi Kondo

Blood (2024) 144 (Supplement 1): 2930.

https://doi.org/10.1182/blood-2024-198943

Published: 2024

Journal Articles

Genetic Mutation and Outcome of Venetoclax-Based Therapy in Newly Diagnosed AML in the Real World: Hokkaido Leukemia Net Study

Blood (2023) 142 (Supplement 1): 1470.

https://doi.org/10.1182/blood-2023-173909

Published: 2023

Journal Articles

Subclinical Minute FLT3 -ITD Clone Can be Detected in Clinically FLT3 -ITD-Negative Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 9094–9095.

https://doi.org/10.1182/blood-2022-162325

Published: 2022

Journal Articles

Prognostic Impact of CEBPA bZIP Domain Mutation in Cytogenetically Normal Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 8950–8951.

https://doi.org/10.1182/blood-2022-158653

Published: 2022

Journal Articles

Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies

Akio Mori, Masahiro Onozawa, Mirei Kobayashi, Shihori Tsukamoto, Hajime Senjo, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Haruna Muraki, Masanobu Morioka, Takanori Teshima, Takeshi Kondo

Blood (2022) 140 (Supplement 1): 9781–9782.

https://doi.org/10.1182/blood-2022-159849

Published: 2022

Journal Articles

Better Prognosis of Dominant-Negative Type of IKZF1 Deletion in BCR-ABL- positive Adult B-Cell Acute Lymphoblastic Leukemia

Blood (2022) 140 (Supplement 1): 9207–9208.

https://doi.org/10.1182/blood-2022-157881

Published: 2022

Journal Articles

Clinical Features of Complex Karyotype in Newly Diagnosed Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 3210–3211.

https://doi.org/10.1182/blood-2022-157874

Published: 2022

Journal Articles

Non-Age-Related Neoplastic Loss of Sex Chromosomecorrelated to Prolonged Survival in CBF-AML Patients in Real-World Clinical Setting

Blood (2021) 138 (Supplement 1): 2378.

https://doi.org/10.1182/blood-2021-146276

Published: 2021

Journal Articles

High CRP-Albumin Ratio Predicts Poor Prognosis in Transplant Ineligible Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Hajime Senjo, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama, Satoshi Yamamoto, Yutaka Tsutsumi, Yoshihito Haseyama, Takahiro Nagashima, Akio Mori, Shuichi Ota, Hajime Sakai, Toshimichi Ishihara, Takuto Miyagishima, Yasutaka Kakinoki, Mitsutoshi Kurosawa, Hajime Kobayashi, Hiroshi Iwasaki, Takeshi Kondo, Takanori Teshima

Blood (2021) 138 (Supplement 1): 3388.

https://doi.org/10.1182/blood-2021-144832

Published: 2021

Journal Articles

Dynamic Change of Peripheral Blood WT1-mRNA within Three Cycles of Azacitidine Therapy Predicts Treatment Response in High-Risk Myelodysplastic Syndrome

Shinpei Harada, Masahiro Onozawa, Daisuke Hidaka, MD, Shota Yokoyama, Hajime Senjo, MD, Shogo Takahashi, MD, Reiki Ogasawara, MDPhD, Akio Mori, Shuichi Ota, Takeshi Kondo, MD PhD, Takanori Teshima, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-138377

Published: 2020

Journal Articles

Modified Conut Score Can Predict Prognosis in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Hajime Senjo, MD, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama, Satoshi Yamamoto, MD PhD, Yutaka Tsutsumi, Yoshihito Haseyama, Takahiro Nagashima, Akio Mori, Shuichi Ota, Hajime Sakai, Toshimichi Ishihara, Takuto Miyagishima, Yasutaka Kakinoki, Mitsutoshi Kurosawa, Hajime Kobayashi, Hiroshi Iwasaki, Takeshi Kondo, Takanori Teshima, MD

Blood (2019) 134 (Supplement_1): 3854.

https://doi.org/10.1182/blood-2019-122804

Published: 2019

Journal Articles

High Metabolic Heterogeneity on Baseline 18F-FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Diffuse Large B-Cell Lymphoma

Hajime Senjo, MD, Kenji Hirata, MD PhD, Koh Izumiyama, MD PhD, Koichiro Minauchi, MD, Kazuo Itoh, Eriko Tsukamoto, Akio Mori, Shuichi Ota, Daigo Hashimoto, Takanori Teshima, MD

Blood (2019) 134 (Supplement_1): 488.

https://doi.org/10.1182/blood-2019-124390

Published: 2019

Journal Articles

Serum Soluble Interleukin-2 Receptor As a Surrogate Biomarker of Metabolic Tumor Volume Measured By 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma

Hajime Senjo, MD, Minoru Kanaya, MDPhD, Koh Izumiyama, MDPhD, Koichiro Minauchi, MD, Kenji Hirata, MDPhD, Akio Mori, Makoto Saito, Masanori Tanaka, Hiroaki Iijima, Eriko Tsukamoto, Kazuo Itoh, Shuichi Ota, MD, Masanobu Morioka, Daigo Hashimoto, MD, PhD, Takanori Teshima

Blood (2018) 132 (Supplement 1): 345.

https://doi.org/10.1182/blood-2018-99-111076

Published: 2018

Journal Articles

A Chimeric Gene, FIP1L1-RARα, Is Isolated from t(4;17)-Positive Acute Promyelocytic Leukemia; a Report of Cloning and Functional Analysis.

Takeshi Kondo, MD, PhD, Akio Mori, MD, PhD, Masahiro Onozawa, MD, PhD, Kaoru Kahata, MD, PhD, Satoshi Hashino, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masanobu Morioka, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2007) 110 (11): 1820.

https://doi.org/10.1182/blood.V110.11.1820.1820

Published: 2007

Journal Articles

CD56 Expression Is the Potent Prognostic Marker of the Thalidomide Efficacy in the Patients with Multiple Myeloma.

Akio Mori, MD, PhD, Yutaka Tsutsumi, MD, PhD, Satoshi Hashino, MD, PhD, Hiroe Kanamori, MD, Makoto Ibata, MD, Shinobu Mashiko, MD, Nobuo Masauzi, MD, PhD, Masahiro Asaka, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2005) 106 (11): 5142.

https://doi.org/10.1182/blood.V106.11.5142.5142

Published: 2005

Journal Articles

Cytolytic activity and regulatory functions of inhibitory NK cell receptor–expressing T cells expanded from granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells

Junji Tanaka, Tomomi Toubai, Yutaka Tsutsumi, Yoko Miura, Naoko Kato, Shintarou Umehara, Kaoru Kahata, Akio Mori, Nobuyasu Toyoshima, Shuichi Ota, Takahiko Kobayashi, Masanobu Kobayashi, Masaharu Kasai, Masahiro Asaka, Masahiro Imamura

Blood (2004) 104 (3): 768–774.

https://doi.org/10.1182/blood-2003-11-3870

Published: 2004

Journal Articles

Two Distinct Pathways of Interleukin-5 Synthesis in Allergen-Specific Human T-Cell Clones Are Suppressed by Glucocorticoids

Akio Mori, Osamu Kaminuma, Matsunobu Suko, Satoshi Inoue, Takeo Ohmura, Akihiko Hoshino, Yumiko Asakura, Keiji Miyazawa, Toyokazu Yokota, Yasushi Okumura, Koji Ito, Hirokazu Okudaira

Blood (1997) 89 (8): 2891–2900.

https://doi.org/10.1182/blood.V89.8.2891

Published: 1997

NARROW

Evaluation of Lymphocyte Immunity in Patients Treated with Venetoclax-Azacitidine for Acute Myeloid Leukemia

Combination of Low White Blood Cell Count and Impaired Renal Function Is a Risk Factor for Higher Concentrations of Venetoclax and Prolonged Neutropenia in AML Patients with Venetoclax Combined Regimen: Real World Experience in the Japanese Cohort

Genetic Mutation and Outcome of Venetoclax-Based Therapy in Newly Diagnosed AML in the Real World: Hokkaido Leukemia Net Study

Subclinical Minute FLT3 -ITD Clone Can be Detected in Clinically FLT3 -ITD-Negative Acute Myeloid Leukemia

Prognostic Impact of CEBPA bZIP Domain Mutation in Cytogenetically Normal Acute Myeloid Leukemia

Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies

Better Prognosis of Dominant-Negative Type of IKZF1 Deletion in BCR-ABL- positive Adult B-Cell Acute Lymphoblastic Leukemia

Clinical Features of Complex Karyotype in Newly Diagnosed Acute Myeloid Leukemia

Non-Age-Related Neoplastic Loss of Sex Chromosomecorrelated to Prolonged Survival in CBF-AML Patients in Real-World Clinical Setting

High CRP-Albumin Ratio Predicts Poor Prognosis in Transplant Ineligible Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Dynamic Change of Peripheral Blood WT1-mRNA within Three Cycles of Azacitidine Therapy Predicts Treatment Response in High-Risk Myelodysplastic Syndrome

Modified Conut Score Can Predict Prognosis in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

High Metabolic Heterogeneity on Baseline 18F-FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Diffuse Large B-Cell Lymphoma

Serum Soluble Interleukin-2 Receptor As a Surrogate Biomarker of Metabolic Tumor Volume Measured By 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma

A Chimeric Gene, FIP1L1-RARα, Is Isolated from t(4;17)-Positive Acute Promyelocytic Leukemia; a Report of Cloning and Functional Analysis.

CD56 Expression Is the Potent Prognostic Marker of the Thalidomide Efficacy in the Patients with Multiple Myeloma.

Cytolytic activity and regulatory functions of inhibitory NK cell receptor–expressing T cells expanded from granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells

Two Distinct Pathways of Interleukin-5 Synthesis in Allergen-Specific Human T-Cell Clones Are Suppressed by Glucocorticoids

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only